Research output: Contribution to journal › Article › peer-review
Autotransplantation of cryopreserved ovarian tissue-effective method of fertility preservation in cancer patients. / Gamzatova, Zaynab; Komlichenko, Eduard; Kostareva, Anna; Galagudza, Mikhail; Ulrikh, Elena; Zubareva, Tatiana; Sheveleva, Tatiana; Nezhentseva, Elena; Kalinina, Evgenia.
In: Gynecological Endocrinology, Vol. 30, 28.08.2014, p. 43-47.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Autotransplantation of cryopreserved ovarian tissue-effective method of fertility preservation in cancer patients
AU - Gamzatova, Zaynab
AU - Komlichenko, Eduard
AU - Kostareva, Anna
AU - Galagudza, Mikhail
AU - Ulrikh, Elena
AU - Zubareva, Tatiana
AU - Sheveleva, Tatiana
AU - Nezhentseva, Elena
AU - Kalinina, Evgenia
N1 - Publisher Copyright: © 2014 Informa UK Ltd.
PY - 2014/8/28
Y1 - 2014/8/28
N2 - Objective: To review the literature and to present the latest advances in the autotransplantation of cryopreserved ovarian tissue. Materials and methods: A literature review was conducted for all relevant articles assessing the fertility preservation, ovarian tissue transplantation, standard freezing and vitrification of ovarian tissue. Results: One of the promising and effective methods for fertility preservation may be the autotransplantation of cryopreserved ovarian tissue. At present, 30 babies have been born after orthotopic autotransplantation of frozen-thawed human ovarian tissue. Restoration of ovarian activity occurs between 3.5 months and 6.5 months. The longevity of autotransplanted ovarian tissue is about 5-7 years. The follicles are similarly preserved after all freezing methods; however, the ovarian stroma is significantly better preserved after vitrification than after slow freezing. An important topic for further research is preparation of the "vascular bed", optimization of vitrification technique and the development of alternative procedures to avoid the transmission of cancer cells via ovarian tissue autotransplantation-"artificial ovary". Conclusions: Cryopreservation of ovarian tissue has unique advantages over other strategies. This method: (1) does not delay cancer treatment; (2) is safer for hormone dependent malignancy; (3) can be done independent of menstrual cycles; (4) is the only option for prepubertal girls; (5) can restore not only fertility but endocrine function.
AB - Objective: To review the literature and to present the latest advances in the autotransplantation of cryopreserved ovarian tissue. Materials and methods: A literature review was conducted for all relevant articles assessing the fertility preservation, ovarian tissue transplantation, standard freezing and vitrification of ovarian tissue. Results: One of the promising and effective methods for fertility preservation may be the autotransplantation of cryopreserved ovarian tissue. At present, 30 babies have been born after orthotopic autotransplantation of frozen-thawed human ovarian tissue. Restoration of ovarian activity occurs between 3.5 months and 6.5 months. The longevity of autotransplanted ovarian tissue is about 5-7 years. The follicles are similarly preserved after all freezing methods; however, the ovarian stroma is significantly better preserved after vitrification than after slow freezing. An important topic for further research is preparation of the "vascular bed", optimization of vitrification technique and the development of alternative procedures to avoid the transmission of cancer cells via ovarian tissue autotransplantation-"artificial ovary". Conclusions: Cryopreservation of ovarian tissue has unique advantages over other strategies. This method: (1) does not delay cancer treatment; (2) is safer for hormone dependent malignancy; (3) can be done independent of menstrual cycles; (4) is the only option for prepubertal girls; (5) can restore not only fertility but endocrine function.
KW - Chemotherapy
KW - Fertility preservation
KW - Ovarian tissue transplantation
KW - Radiotherapy
KW - Standard freezing
KW - Vitrification
UR - http://www.scopus.com/inward/record.url?scp=84907058017&partnerID=8YFLogxK
U2 - 10.3109/09513590.2014.945789
DO - 10.3109/09513590.2014.945789
M3 - Article
C2 - 25200829
AN - SCOPUS:84907058017
VL - 30
SP - 43
EP - 47
JO - Gynecological Endocrinology
JF - Gynecological Endocrinology
SN - 0951-3590
ER -
ID: 87785719